0.1703
Finanzdaten der AIM ImmunoTech Inc-Aktie (AIM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
18.18%
0.026
|
0.022 | 0.021 | 0.026 | 0.025 |
| Research and Development |
22.20%
0.589
|
0.482 | 1.063 | - | 1.174 |
| Interest Income/Expense |
2.96%
0.295
|
0.304 | 0.391 | 0.148 | 0.149 |
| Costs And Expenses |
57.43%
3.539
|
2.248 | 2.973 | 2.473 | 2.671 |
| Operating Income/Loss |
57.82%
-3.513
|
-2.226 | -2.952 | -2.447 | -2.646 |
| Net Income/Loss |
25.31%
-3.788
|
-3.023 | -4.175 | -3.284 | -2.794 |
| Basic Average Shares |
293.40%
17.12
|
4.3514 | - | 2.0934 | 0.7593 |
| Diluted Average Shares |
293.40%
17.12
|
4.3514 | - | 2.0934 | 0.7593 |
| Basic Earnings Per Share |
37.68%
-0.43
|
-0.69 | - | 1.57 | -3.68 |
| Diluted Earnings Per Share |
37.68%
-0.43
|
-0.69 | - | 1.57 | -3.68 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):